Correlation Between Alphabet and Sana Biotechnology
Can any of the company-specific risk be diversified away by investing in both Alphabet and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Sana Biotechnology, you can compare the effects of market volatilities on Alphabet and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Sana Biotechnology.
Diversification Opportunities for Alphabet and Sana Biotechnology
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Alphabet and Sana is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Alphabet i.e., Alphabet and Sana Biotechnology go up and down completely randomly.
Pair Corralation between Alphabet and Sana Biotechnology
Given the investment horizon of 90 days Alphabet Inc Class C is expected to generate 0.32 times more return on investment than Sana Biotechnology. However, Alphabet Inc Class C is 3.11 times less risky than Sana Biotechnology. It trades about -0.02 of its potential returns per unit of risk. Sana Biotechnology is currently generating about -0.16 per unit of risk. If you would invest 17,269 in Alphabet Inc Class C on September 1, 2024 and sell it today you would lose (220.00) from holding Alphabet Inc Class C or give up 1.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alphabet Inc Class C vs. Sana Biotechnology
Performance |
| Timeline |
| Alphabet Class C |
| Sana Biotechnology |
Alphabet and Sana Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alphabet and Sana Biotechnology
The main advantage of trading using opposite Alphabet and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.The idea behind Alphabet Inc Class C and Sana Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |